Bank of New York Mellon’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
124,450
+5,733
+5% +$65.3K ﹤0.01% 3076
2026
Q1
$1.35M Sell
118,717
-477
-0.4% -$5.17K ﹤0.01% 3032
2025
Q4
$1.53M Sell
119,194
-750
-0.6% -$9.26K ﹤0.01% 2997
2025
Q3
$1.34M Buy
119,944
+2,556
+2% +$24.7K ﹤0.01% 3040
2025
Q2
$1.16M Sell
117,388
-5,451
-4% -$53.4K ﹤0.01% 3054
2025
Q1
$1.15M Buy
122,839
+163
+0.1% +$1.71K ﹤0.01% 2984
2024
Q4
$1.12M Buy
122,676
+3,815
+3% +$28.1K ﹤0.01% 3084
2024
Q3
$925K Sell
118,861
-55,881
-32% -$404K ﹤0.01% 3183
2024
Q2
$1.06M Buy
174,742
+15,412
+10% +$95.1K ﹤0.01% 3169
2024
Q1
$935K Sell
159,330
-40,878
-20% -$243K ﹤0.01% 3190
2023
Q4
$1.57M Sell
200,208
-23,698
-11% -$164K ﹤0.01% 2953
2023
Q3
$1.64M Sell
223,906
-161,358
-42% -$1.34M ﹤0.01% 2916
2023
Q2
$4.02M Sell
385,264
-18,817
-5% -$181K ﹤0.01% 2446
2023
Q1
$4.18M Sell
404,081
-20,789
-5% -$266K ﹤0.01% 2396
2022
Q4
$5.85M Buy
424,870
+6,171
+1% +$85.8K ﹤0.01% 2250
2022
Q3
$8.57M Buy
418,699
+27,044
+7% +$594K ﹤0.01% 1984
2022
Q2
$7.58M Sell
391,655
-17,692
-4% -$362K ﹤0.01% 2101
2022
Q1
$8.82M Sell
409,347
-4,446
-1% -$101K ﹤0.01% 2135
2021
Q4
$11.4M Buy
413,793
+845
+0.2% +$23.3K ﹤0.01% 2029
2021
Q3
$10.7M Sell
412,948
-42,384
-9% -$1.13M ﹤0.01% 2082
2021
Q2
$12.4M Buy
455,332
+9,268
+2% +$226K ﹤0.01% 2017
2021
Q1
$10.4M Buy
446,064
+11,911
+3% +$241K ﹤0.01% 2065
2020
Q4
$6.66M Buy
434,153
+14,468
+3% +$184K ﹤0.01% 2219
2020
Q3
$5.06M Buy
419,685
+3,583
+0.9% +$34K ﹤0.01% 2209
2020
Q2
$4.23M Buy
416,102
+433
+0.1% +$4.46K ﹤0.01% 2283
2020
Q1
$4.34M Sell
415,669
-7,658
-2% -$96.1K ﹤0.01% 2145
2019
Q4
$6.78M Sell
423,327
-9,336
-2% -$143K ﹤0.01% 2176
2019
Q3
$7.97M Sell
432,663
-16,617
-4% -$325K ﹤0.01% 2047
2019
Q2
$8.85M Sell
449,280
-4,668
-1% -$95.1K ﹤0.01% 2032
2019
Q1
$10.4M Sell
453,948
-1,242
-0.3% -$27K ﹤0.01% 1954
2018
Q4
$9.16M Sell
455,190
-20,971
-4% -$434K ﹤0.01% 1952
2018
Q3
$10.4M Sell
476,161
-59,722
-11% -$1.33M ﹤0.01% 2010
2018
Q2
$11.9M Buy
535,883
+50,533
+10% +$1.03M ﹤0.01% 1925
2018
Q1
$8.37M Buy
485,350
+14,794
+3% +$247K ﹤0.01% 2082
2017
Q4
$7.83M Sell
470,556
-24,577
-5% -$419K ﹤0.01% 2108
2017
Q3
$8.46M Sell
495,133
-44,277
-8% -$744K ﹤0.01% 2067
2017
Q2
$8.74M Buy
539,410
+44,311
+9% +$701K ﹤0.01% 2047
2017
Q1
$8.59M Buy
495,099
+21,277
+4% +$356K ﹤0.01% 2053
2016
Q4
$7.99M Buy
473,822
+54,973
+13% +$917K ﹤0.01% 2074
2016
Q3
$7.35M Sell
418,849
-8,680
-2% -$141K ﹤0.01% 2032
2016
Q2
$6.14M Buy
427,529
+9,502
+2% +$119K ﹤0.01% 2106
2016
Q1
$5.14M Buy
418,027
+99,459
+31% +$1.1M ﹤0.01% 2167
2015
Q4
$3.87M Sell
318,568
-60,163
-16% -$741K ﹤0.01% 2358
2015
Q3
$5M Buy
378,731
+27,573
+8% +$416K ﹤0.01% 2237
2015
Q2
$5.76M Buy
351,158
+4,449
+1% +$73.9K ﹤0.01% 2264
2015
Q1
$6.17M Sell
346,709
-11,075
-3% -$206K ﹤0.01% 2201
2014
Q4
$6.8M Buy
357,784
+117,141
+49% +$1.98M ﹤0.01% 2144
2014
Q3
$3.3M Buy
240,643
+43,552
+22% +$622K ﹤0.01% 2557
2014
Q2
$3.22M Sell
197,091
-4,099
-2% -$59.3K ﹤0.01% 2615
2014
Q1
$3.17M Buy
201,190
+10,570
+6% +$172K ﹤0.01% 2580
2013
Q4
$3.27M Sell
190,620
-16,380
-8% -$252K ﹤0.01% 2562
2013
Q3
$2.73M Buy
207,000
+12,064
+6% +$142K ﹤0.01% 2638
2013
Q2
$2.2M Buy
+194,936
New +$2.07M ﹤0.01% 2732

Other funds holding ANGO

Bank of New York Mellon's ANGO Position: Q2 2026 in Review

Bank of New York Mellon increased its AngioDynamics (ANGO) stake by 4.8% in Q2 2026, buying an estimated $65.3K and bringing the position to 124,450 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

Bank of New York Mellon first reported a position in ANGO in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.4M in Q2 2021. 83 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Bank of New York Mellon held 124,450 shares of AngioDynamics worth $1.62M as of Q2 2026.
  • Bank of New York Mellon bought 5,733 AngioDynamics shares in Q2 2026, an estimated $65.3K.
  • AngioDynamics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3076 holding.
  • Bank of New York Mellon first reported a position in AngioDynamics in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's AngioDynamics position peaked at $12.4M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.